Stock Price Quote

VIYASH SCIENTIFIC LTD.

NSE : VIYASHBSE : 512529ISIN CODE : INE807F01027Industry : Pharmaceuticals & DrugsHouse : Sequent
BSE261.00-0.8 (-0.31 %)
PREV CLOSE ( ) 261.80
OPEN PRICE ( ) 261.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10420
TODAY'S LOW / HIGH ( )260.70 263.15
52 WK LOW / HIGH ( )178.4 297.9
NSE259.85-2.05 (-0.78 %)
PREV CLOSE( ) 261.90
OPEN PRICE ( ) 261.00
BID PRICE (QTY) 259.80 (502)
OFFER PRICE (QTY) 259.85 (98)
VOLUME 620278
TODAY'S LOW / HIGH( ) 259.75 263.40
52 WK LOW / HIGH ( )178.13 298
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-06 1985
Management Info
Kamal Sharma - Chairman Haribabu Bodepudi - Managing Director
Registered Office

Address 3rd Floor, Srivalli’s Corporate, Plot No.290, Road No.6,Sy. No.33, 34 P To 39, Guttala Begumpet,Guttala Begumpet, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040 23635000

Email investorrelations@viyash.com

Website www.viyash.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

04Sep Viyash Scientific informs about allotm
Viyash Scientific has informed that the Nomination and Remuneration Comm..
11Jun Viyash Scientific informs about analys
Pursuant to Regulation 30 of the SEBI Listing Regulations, Viyash Scient..
08Jun Viyash Scientific signs binding agreem
Viyash Scientific, through its wholly owned subsidiary Alivira Animal He..
08Jun Viyash Scientific informs about acquis
Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Reg..
12May Viyash Scientific informs about board
Viyash Scientific has informed that the meeting of the Board of Director..

Financials

in Millions
QTR Jun 26 ANNUAL 26
Net Profit209.2758.700000000002
Gross Profit 278.9 1162.2
Operating Profit 617.43007.9
Net Sales 3536.913820.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  23724.40 (2.04%)
M.Cap ( in Cr)30259.16
Acutaas Chemicals (BSE)
peergroup  3315.00 (2.53%)
M.Cap ( in Cr)26455.02
Abbott India (BSE)
peergroup  25272.35 (0.19%)
M.Cap ( in Cr)53792.61
Torrent Pharma (BSE)
peergroup  4974.85 (0.87%)
M.Cap ( in Cr)188183.19
Caplin Point Labs. (BSE)
peergroup  2768.60 (1.54%)
M.Cap ( in Cr)20758.79

Shareholding Pattern

PROMOTERS 61.31%
NON-INSTITUTION 30.43%
MUTUAL FUNDS/UTI 2.93%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Viyash Scientific Ltd.

Viyash Scientific Ltd. was incorporated in the year 1985. Its today's share price is 261. Its current market capitalisation stands at Rs 11548.24 Cr. In the latest quarter, company has reported Gross Sales of Rs. 13820.58 Cr and Total Income of Rs.14483.15 Cr. The company's management includes Abhiroop Jayanthi, Haribabu Bodepudi, Anuj Poddar, Amit Jain, Revati Kasture, Milind Sarwate, Srinivas Vasireddy, Rajaram Narayanan, Kamal Sharma, Yoshita Vora.

It is listed on the BSE with a BSE Code of 512529 , NSE with an NSE Symbol of VIYASH and ISIN of INE807F01027. It's Registered office is at 3rd Floor, Srivalli’s Corporate, Plot No.290, Road No.6,Sy. No.33, 34 P To 39, Guttala Begumpet,Guttala Begumpet, Jubilee HillsHyderabad-500033, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells, Deloittee Haskins & Sells, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.